Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance. - Test2 - elhamkhani - TriplyDB

Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance.

Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance.

http://www.wikidata.org/entity/Q40068246

about

Identification and functional analysis of a novel cyclin e/cdk2 substrate ankrd17 Gradually elevated expression of Gankyrin during human hepatocarcinogenesis and its clinicopathological significance Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma.Gankyrin is frequently overexpressed in cervical high grade disease and is associated with cervical carcinogenesis and metastasis Prognostic and clinicopathological significance of Gankyrin overexpression in cancers: evidence from a meta-analysis YAP is a critical oncogene in human cholangiocarcinoma Up-regulated oncoprotein P28GANK correlates with proliferation and poor prognosis of human glioma.Scratching the Surface: Resurfacing Proteins to Endow New Properties and Function.Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer.Gankyrin promotes the proliferation of gastric cancer and is associated with chemosensitivity.Gankyrin regulates cell signaling network.Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway.Expression of the oncoprotein gankyrin and phosphorylated retinoblastoma protein in human testis and testicular germ cell tumor.Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity.p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways.Resurfaced shape complementary proteins that selectively bind the oncoprotein gankyrin.The Plasticizer Bisphenol A Perturbs the Hepatic Epigenome: A Systems Level Analysis of the miRNome.Unexpected Lower Expression of Oncoprotein Gankyrin in Drug Resistant ABCG2 Overexpressing Breast Cancer Cell Lines Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma.Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.

P2860

Q24317434-8E5A0C6A-34A4-43FC-802E-A3749DACE6D1 Q33851157-CDDF3A18-44D4-42A5-9826-ED8233945AB3 Q34619226-9172A392-EAA8-428C-B5E1-56B5D1C8C5F5 Q35153915-F9619A6E-3E97-4290-9DD4-020A781735AE Q35997896-77426695-3B23-496E-A143-921022ADA87F Q36232005-3CDB9B3D-17F5-49F6-BF05-295C6DCEEB33 Q36235734-1406C3CC-CF66-4DE4-9B2C-30CDB007F854 Q36945870-E5AD7F83-43EB-4242-A205-76F85E1B9AC8 Q37697139-4F08205C-11D7-43B1-9E68-915486FBD24F Q37701508-D99D51E2-F622-4A38-B601-A8F97F5F4174 Q37880852-216E75D1-D96D-4F96-AF41-9733EE2E660E Q38698888-743DEE5B-F2A3-456C-AF56-3D00A6D5E229 Q38714564-B2BDCD53-0BFF-459C-B8C1-7BCC2DDE6D4D Q38835733-DCBAF775-825D-45DD-A68C-BD1530630151 Q38991575-687A7918-FB14-44CC-A8EA-C282B4F8C793 Q39298025-FE6E88B6-53CC-41E3-8A65-AEF8C6F8F3E1 Q39604806-F6EFF0E0-2FDE-491D-9F8C-0088885D7084 Q42548703-BF9C000B-26A7-4A8D-B438-B64438566BA0 Q46024647-190AB1BE-2545-474D-87C3-5EC5EAE65FF6 Q47245509-A2B10375-29EB-4979-9275-A6FAB67B72B1 Q47661011-8C368A0E-F9DE-4F20-9529-F798807B8269 Q53090136-7459C4C7-5551-442A-AEAF-FB8A61DA11AD

P2860

Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance.

http://www.wikidata.org/entity/Q40068246

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Gankyrin oncoprotein overexpre ...... and its clinical significance.

@en

type

label

Gankyrin oncoprotein overexpre ...... and its clinical significance.

@en

prefLabel

Gankyrin oncoprotein overexpre ...... and its clinical significance.

@en

P1433

Q40068246-32D667C3-96E7-4501-A781-BEC1541B959F

P1476

Q40068246-821E82E0-B9C8-4FB3-B1B2-347602925195

P2093

Q40068246-0770C433-8F75-429E-9B3B-B013CF90FD6C

Q40068246-3656D669-0223-4506-9E14-09E02D2820CC

Q40068246-534BE51E-02A9-4200-9E9C-05FD6DD0162B

Q40068246-581DF0F8-DD69-4907-987D-2B8AFB7D5A57

Q40068246-6234B584-BAFF-4E0B-9C5D-E3999D310D91

Q40068246-7F43834A-05C0-4484-8059-F08ACECBA4A6

Q40068246-ACB10783-4797-4C74-B9C6-9F3FFC1E0F4A

Q40068246-C9C5CBD0-C291-41C3-86C7-B3A2AFE0EE03

Q40068246-F4BA7491-FF85-4C3E-B11A-A239FA999AD2

P2860

Q40068246-01AE9321-1A0A-462E-B06A-80F642743B71

Q40068246-03BFD545-C96B-49AB-87BA-A15D8754345B

Q40068246-24E8ABBB-C854-44D7-8D39-6102F5F86CA7

Q40068246-30C5C62D-BCE4-4D6B-AC2E-4ECC69B74EB7

Q40068246-31BBC69B-30ED-452C-9EAC-44A9D7C31B3F

Q40068246-439B4A3D-4B45-4B2F-BE54-26D06BCEB0AD

Q40068246-4628F8BB-43C3-4003-814B-002F8BD2B11B

Q40068246-4725A2D5-6DD3-4121-B58C-6056B61F17E7

Q40068246-48BDF7B8-4749-48F8-B4FE-938040F37D2F

Q40068246-49E671F7-67FD-4746-8FC2-3A7F1673B97F

P304

Q40068246-BE2AE4D8-0762-4514-BCB4-52C79C807FEB

P31

Q40068246-B44B0604-5B8D-462F-BAA7-9FDFAAB583A8

P356

Q40068246-C0CBAA9D-E9BB-4C0C-96D0-540B24846C59

P433

Q40068246-5EF66664-A0C0-4585-9F8D-CB1228AB372D

P478

Q40068246-8E337F4C-3FD1-40B3-9A34-0BBE0345ED42

P577

Q40068246-6781516D-8979-4A0E-B116-77EA45E0E213

P5875

Q40068246-831E0CDC-50DB-4EA3-8327-39330B1BF5DD

P698

Q40068246-0894CF01-3A5B-4086-8BBC-F36B92BAE35F

P921

Q40068246-5EA37780-EDE6-4957-BF7F-EE86255C5F00

P356

P1433

International Journal of Cancer

P1476

Gankyrin oncoprotein overexpre ...... and its clinical significance.

@en

P2093

Cristian M Ortiz

http://www.w3.org/2001/XMLSchema#string

Eiji Tanaka

http://www.w3.org/2001/XMLSchema#string

Hiroaki Higashitsuji

http://www.w3.org/2001/XMLSchema#string

Jun Fujita

http://www.w3.org/2001/XMLSchema#string

Satoshi Nagayama

http://www.w3.org/2001/XMLSchema#string

Shigeru Tsunoda

http://www.w3.org/2001/XMLSchema#string

Tetsuo Ito

http://www.w3.org/2001/XMLSchema#string

Yoshiharu Sakai

http://www.w3.org/2001/XMLSchema#string

Yutaka Shimada

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas

Novel insights into the INK4-CDK4/6-Rb pathway: counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb

A cleaved form of MAGE-A4 binds to Miz-1 and induces apoptosis in human cells

The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53

cDNA cloning and functional analysis of p28 (Nas6p) and p40.5 (Nas7p), two novel regulatory subunits of the 26S proteasome

MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53

Crystal structure of the homolog of the oncoprotein gankyrin, an interactor of Rb and CDK4/6

Surfing the p53 network

P304

325-332

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.23106

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5910489

http://www.w3.org/2001/XMLSchema#string

P698

17935131

http://www.w3.org/2001/XMLSchema#string

P921